Hormonal IUD is the major hormonal contraceptive method used among women aged 40 –49 years: Data from the 2015 –16 Tromsø Study, Norw

Objective - This study aims to investigate hormonal contraceptive (HC) use and user characteristics in women aged 40–49 years in Norway, as little is known on use of HCs in this age segment. Material and methods - This prevalence study included 2296 women aged 40–49 years who participated in the 201...

Full description

Bibliographic Details
Published in:European Journal of Obstetrics & Gynecology and Reproductive Biology
Main Authors: Bjørkås, Merethe, Skjeldestad, Finn Egil
Format: Article in Journal/Newspaper
Language:English
Published: Elsevier 2022
Subjects:
Online Access:https://hdl.handle.net/10037/28519
https://doi.org/10.1016/j.ejogrb.2022.11.019
id ftunivtroemsoe:oai:munin.uit.no:10037/28519
record_format openpolar
spelling ftunivtroemsoe:oai:munin.uit.no:10037/28519 2023-05-15T18:34:21+02:00 Hormonal IUD is the major hormonal contraceptive method used among women aged 40 –49 years: Data from the 2015 –16 Tromsø Study, Norw Bjørkås, Merethe Skjeldestad, Finn Egil 2022-11-23 https://hdl.handle.net/10037/28519 https://doi.org/10.1016/j.ejogrb.2022.11.019 eng eng Elsevier European Journal of Obstetrics, Gynecology, and Reproductive Biology Bjørkås, Skjeldestad. Hormonal IUD is the major hormonal contraceptive method used among women aged 40 –49 years: Data from the 2015 –16 Tromsø Study, Norw. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2022 FRIDAID 2113371 doi:10.1016/j.ejogrb.2022.11.019 0301-2115 1872-7654 https://hdl.handle.net/10037/28519 Attribution 4.0 International (CC BY 4.0) openAccess Copyright 2022 The Author(s) https://creativecommons.org/licenses/by/4.0 CC-BY Journal article Tidsskriftartikkel Peer reviewed acceptedVersion 2022 ftunivtroemsoe https://doi.org/10.1016/j.ejogrb.2022.11.019 2023-02-09T00:03:55Z Objective - This study aims to investigate hormonal contraceptive (HC) use and user characteristics in women aged 40–49 years in Norway, as little is known on use of HCs in this age segment. Material and methods - This prevalence study included 2296 women aged 40–49 years who participated in the 2015–16 Tromsø Study, which collected self-reported sociodemographic information and data from a wide range of validated health questionnaires. The participants had been sexually active the last 12 months prior enrollment, were not pregnant, not trying to conceive, and had no prior fertility problems. We categorized use of HC into three groups; no HC use, hormonal IUD use and other HC use. Explanatory variables included demographic, educational, economic and general health variables. All analyses were performed in SPSS with chi-square test and logistic regression at significance level p < 0.05. Results - Nearly 50 % of the study sample reported HC use with hormonal IUD use as the major method (39.5 %/40–44 years; 43.4 %/45–49 years old women). There were no differences in HC use by partner status, educational level, or BMI. Though statistically significant, we found only minor differences in HC use by occupational status, gross household income, and general health status, with higher proportions of women with no paid work, the lowest income, and poor health status reporting no HC use. Conclusion - The high HC use and the minor differences found across demographic and socioeconomic parameters indicate that HC use, and hormonal IUD use in particular, is widely used among middle-aged women living in the city of Tromsø. Article in Journal/Newspaper Tromsø University of Tromsø: Munin Open Research Archive Norway Tromsø European Journal of Obstetrics & Gynecology and Reproductive Biology 280 93 97
institution Open Polar
collection University of Tromsø: Munin Open Research Archive
op_collection_id ftunivtroemsoe
language English
description Objective - This study aims to investigate hormonal contraceptive (HC) use and user characteristics in women aged 40–49 years in Norway, as little is known on use of HCs in this age segment. Material and methods - This prevalence study included 2296 women aged 40–49 years who participated in the 2015–16 Tromsø Study, which collected self-reported sociodemographic information and data from a wide range of validated health questionnaires. The participants had been sexually active the last 12 months prior enrollment, were not pregnant, not trying to conceive, and had no prior fertility problems. We categorized use of HC into three groups; no HC use, hormonal IUD use and other HC use. Explanatory variables included demographic, educational, economic and general health variables. All analyses were performed in SPSS with chi-square test and logistic regression at significance level p < 0.05. Results - Nearly 50 % of the study sample reported HC use with hormonal IUD use as the major method (39.5 %/40–44 years; 43.4 %/45–49 years old women). There were no differences in HC use by partner status, educational level, or BMI. Though statistically significant, we found only minor differences in HC use by occupational status, gross household income, and general health status, with higher proportions of women with no paid work, the lowest income, and poor health status reporting no HC use. Conclusion - The high HC use and the minor differences found across demographic and socioeconomic parameters indicate that HC use, and hormonal IUD use in particular, is widely used among middle-aged women living in the city of Tromsø.
format Article in Journal/Newspaper
author Bjørkås, Merethe
Skjeldestad, Finn Egil
spellingShingle Bjørkås, Merethe
Skjeldestad, Finn Egil
Hormonal IUD is the major hormonal contraceptive method used among women aged 40 –49 years: Data from the 2015 –16 Tromsø Study, Norw
author_facet Bjørkås, Merethe
Skjeldestad, Finn Egil
author_sort Bjørkås, Merethe
title Hormonal IUD is the major hormonal contraceptive method used among women aged 40 –49 years: Data from the 2015 –16 Tromsø Study, Norw
title_short Hormonal IUD is the major hormonal contraceptive method used among women aged 40 –49 years: Data from the 2015 –16 Tromsø Study, Norw
title_full Hormonal IUD is the major hormonal contraceptive method used among women aged 40 –49 years: Data from the 2015 –16 Tromsø Study, Norw
title_fullStr Hormonal IUD is the major hormonal contraceptive method used among women aged 40 –49 years: Data from the 2015 –16 Tromsø Study, Norw
title_full_unstemmed Hormonal IUD is the major hormonal contraceptive method used among women aged 40 –49 years: Data from the 2015 –16 Tromsø Study, Norw
title_sort hormonal iud is the major hormonal contraceptive method used among women aged 40 –49 years: data from the 2015 –16 tromsø study, norw
publisher Elsevier
publishDate 2022
url https://hdl.handle.net/10037/28519
https://doi.org/10.1016/j.ejogrb.2022.11.019
geographic Norway
Tromsø
geographic_facet Norway
Tromsø
genre Tromsø
genre_facet Tromsø
op_relation European Journal of Obstetrics, Gynecology, and Reproductive Biology
Bjørkås, Skjeldestad. Hormonal IUD is the major hormonal contraceptive method used among women aged 40 –49 years: Data from the 2015 –16 Tromsø Study, Norw. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2022
FRIDAID 2113371
doi:10.1016/j.ejogrb.2022.11.019
0301-2115
1872-7654
https://hdl.handle.net/10037/28519
op_rights Attribution 4.0 International (CC BY 4.0)
openAccess
Copyright 2022 The Author(s)
https://creativecommons.org/licenses/by/4.0
op_rightsnorm CC-BY
op_doi https://doi.org/10.1016/j.ejogrb.2022.11.019
container_title European Journal of Obstetrics & Gynecology and Reproductive Biology
container_volume 280
container_start_page 93
op_container_end_page 97
_version_ 1766219051708710912